Commercial Services and Supplies
Company Overview of Medical Research Council
Medical Research Council is based in London, United Kingdom.
One Kemble Street
London, WC2B 4AN
Founded in 1913
Key Executives for Medical Research Council
Deputy Chief Executive, Chief of Strategy and Director of National Institute for Medical Research
Director of External Affairs
Compensation as of Fiscal Year 2014.
Medical Research Council Key Developments
Medical Research Council Appoints Sharmila Nebhrajani OBE as Director of External Affairs, Effective from February 23, 2015
Feb 12 15
The Medical Research Council announced the appointment of Sharmila Nebhrajani OBE as Director of External Affairs, from February 23, 2015. Shar is currently Chair of the Human Tissue Authority. Her responsibilities for the MRC include leading on the MRCs engagement with key stakeholders, in particular Parliamentarians and Government, on the importance and impact of the MRCs work and achievements; she will also contribute to the forthcoming Spending Review. Shar will be working closely with other medical research funders and academies, and with industry partners.
IXICO plc Joins Collaboration with the Medical Research Council to Accelerate Research into Dementia
Jun 19 14
IXICO plc provided announcement from the Medical Research Council (MRC) that it has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up to speed up research into dementias. IXICO will act as the MRC's imaging partner on the project, alongside other industry partners Araclon, MedImmune, GlaxoSmithKline, Janssen Research & Development and SomaLogic. UKDP will investigate the causes of dementia across a range of different neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease and motor neurone disease. The aim is to enable earlier detection, improved treatment and disease prevention.
Somalogic Joins UK Dementias Research Platform
Jun 19 14
SomaLogic announced that is a launch partner of the Medical Research Council's UK Dementias Research Platform, a £16 million ($27 million) public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease, by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body. The UKDP brings together both industry expertise and investigator teams from eight universities, and teams them with what will be the group of participants in dementias research (more than two million people). The Platform will investigate the causes of dementia across a range of different neurodegenerative conditions, such as Alzheimer’s, Parkinson’s and motor neurone disease.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|